EGLT News Alert Egalet Corp (EGLT) 6.84 11/13/2014 17:00:22

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Egalet Corp (EGLT) 6.84 $EGLT

Egalet's (EGLT) CEO Bob Radie on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 12, 11:18AM CST

EGLT: 6.84 (+0.35)

Egalet net loss worsens in Q3
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 9:29AM CST

EGLT: 6.84 (+0.35)

Egalet beats by $0.14
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 5:41AM CST

EGLT: 6.84 (+0.35)

Egalet Reports Third Quarter 2014 Financial Results and Provides Business Update
PR Newswire - Wed Nov 12, 5:00AM CST
Egalet Corporation (Nasdaq: EGLT) ("Egalet" today reported business highlights and financial results for the three months ended September 30, 2014.
EGLT: 6.84 (+0.35)

Cancer Pain Therapeutics Pipeline Report 2014 - 30 Companies & 43 Drug Profiles
M2 - Thu Nov 06, 4:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/9s5fww/cancer_pain) has announced the addition of the "Cancer Pain - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Cancer Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cancer Pain and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Amgen Inc. - AstraZeneca PLC - BioDelivery Sciences International, Inc. - Nektar Therapeutics - Daiichi Sankyo Company, Limited - Egalet Corporation - Aphios Corporation - Nippon Kayaku Co., Ltd. - Nippon Shinyaku Co., Ltd. - Orion Oyj - Pfizer Inc. - Zeria Pharmaceutical Co Ltd - GW Pharmaceuticals plc - IntelGenx Corp. - Benitec Biopharma Limited - Kolon Life Science, Inc. - Teikoku Seiyaku Co., Ltd. - Aoxing Pharmaceutical Company, Inc - BCN Peptides, S.A. - Grunenthal GmbH - AngioChem Inc. - WEX Pharmaceuticals Inc. - Virobay Inc. - Dimerix Bioscience Pty Ltd - Winston Pharmaceuticals, Inc. - Encore Therapeutics Inc. - Sorrento Therapeutics, Inc. - Afferent Pharmaceuticals, Inc. - ChironWells GmbH - Northern Light Pharmaceuticals AB For more information visit http://www.researchandmarkets.com/research/9s...ancer_pain
BDSI: 15.33 (-0.62), PFE: 30.42 (unch), AMGN: 160.85 (-1.08), AXN: 0.25 (unch), SRNE: 4.21 (-0.23), NKTR: 13.86 (-0.11), EGLT: 6.84 (+0.35), AZN: 74.53 (+0.27), VBAY: ()

Egalet to Present at the Stifel 2014 Healthcare Conference on November 18
GlobeNewswire - Wed Nov 05, 7:30AM CST
Egalet Corporation (Nasdaq:EGLT) ("Egalet" today announced that Bob Radie, president and chief executive officer, is scheduled to present at the Stifel 2014 Healthcare Conference on Tuesday, November 18, 2014 at 4:10 p.m. EST. The conference will be held at the New York Palace Hotel.
EGLT: 6.84 (+0.35)

Nasdaq stocks posting largest percentage decreases
AP - Tue Nov 04, 12:22PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
VTNR: 5.21 (-0.86), EGLT: 6.84 (+0.35), BRDR: 7.34 (+0.22), ALIM: 5.17 (-0.04), ACHN: 13.49 (-1.36), VLCCF: 6.78 (-0.75), REXX: 7.29 (-0.26), FNHC: 25.05 (-0.73), ARCP: 8.81 (+0.02), CKEC: 28.48 (+0.08), PCLN: 1,168.01 (+7.01)

Egalet to Host Conference Call and Webcast to Discuss Third Quarter Financial Results on November 12, 2014
PR Newswire - Wed Oct 29, 7:30AM CDT
Egalet Corporation (Nasdaq: EGLT) ("Egalet" today announced that its third quarter financial results will be released on Wednesday, November 12, 2014. Following the announcement, Egalet's management will host a live conference call and webcast at 8:30 am Eastern Time to review the Company's financial and operating results and provide a general business update.
EGLT: 6.84 (+0.35)

FDA clears Pfizer's abuse deterrent pain med
Seeking Alpha - at Seeking Alpha - Fri Oct 17, 4:20PM CDT

MNK: 86.96 (-6.03), EGLT: 6.84 (+0.35), ZGNX: 1.25 (-0.08), PFE: 30.42 (unch), TEVA: 57.17 (-1.27), ABBV: 63.63 (-0.13), ALKS: 53.22 (+0.22), ACUR: 0.56 (-0.03)

2 Oversold Stocks Under $10 Ready to Bounce Higher
at The Street - Fri Oct 17, 8:05AM CDT
Oversold can always get more oversold, but it's also an area from which a stock can experience a powerful bounce higher.
AMKR: 6.39 (-0.05), EGLT: 6.84 (+0.35)

Egalet (EGLT) Shows Strength: Stock Moves 7.1% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 8:46AM CDT
Egalet (EGLT) was a big mover last session, with shares rising over 7% on the day.
LCI: 48.28 (-1.45), EGLT: 6.84 (+0.35), SHPG: 202.42 (+1.91), CEMP: 14.16 (-0.01)

Egalet Announces Update on Clinical Development Plan for Abuse-Deterrent Morphine Egalet-001
GlobeNewswire - Tue Sep 23, 3:00PM CDT
Egalet Corporation (Nasdaq:EGLT) (Egalet) today announced an update to the clinical development plan for Egalet-001, an abuse-deterrent, extended-release, oral morphine product in development for the management of pain severe enough to require daily, around-the-clock opioid treatment and for which alternative treatments are inadequate. Based on the clinical data generated thus far, the Company will need to conduct additional clinical trials to strengthen the new drug application (NDA) for Egalet-001. Egalet plans to schedule a meeting in the fourth quarter of 2014 with the U.S. Food and Drug Administration (FDA) to discuss the totality of the clinical data from the studies completed and the appropriate registration path forward for Egalet-001.
EGLT: 6.84 (+0.35)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fan Creations Shine: McLaren's Unique Livery Unveiled

Updated Category News Views 47

From Sticker Dreams to Racing Reality Some days bring surprises outside the typical ticker watch as those market charts get shoved aside, right when fans' stories race onto the scene. What McLaren and Velo cooked up for the Mexico City Grand Prix has got me pausing—a blend of motorsport passion and grassroots creativity. By unveiling the 'Livery of Dreams,' McLaren puts...

Continue Reading
Data Centers Drive Surge in Power and Cooling Demand

Updated Category News Views 103

Data Centers: The Unseen Powerhouses Don't let the tech jargon fool you—data centers are more than just server rooms. They're beastly energy guzzlers, and their demand is rippling through the supply chain in a big way. You've got companies like Vertiv, American Tower, Johnson Controls, and Generac riding high on this trend, making some serious waves in their quarterly...

Continue Reading
SELCO and Numerica Unite: A Merger That's All Heart

Updated Category News Views 105

Big Merger in Credit Union World: SELCO and Numerica Sometimes, it ain't all about dollars and cents. That's the vibe I'm picking up from this merger of equals between SELCO Community and Numerica Credit Unions. This isn't a Wall Street hustle, it's hometown hustle—where the biggest reward isn't just a fat line at the bottom but seeing your community thrive. The Vision...

Continue Reading
Tabañero Spices Up Holidays with $10 Gift Sets

Updated Category News Views 160

Hot Sauce, Spicy Gifting, and Bold Barbecue When holiday cheer mixes with a dash of heat, you end up with something as electrifying as Tabañero's latest offerings. This Florida-based player is nudging its way into the gift-giving scene with a lineup that's as spicy as it is thoughtful. Frankly, if you're scrambling for stocking stuffers or a memorable Secret Santa...

Continue Reading
Review Insurance Coverage After Major Life Changes

Updated Category News Views 101

Why Life Changes Demand an Insurance Review The nitty-gritty of life doesn't sit still—marriages, babies, job changes, and home deals or steals each bring their own clutter to the table. One thing's for sure: when your life shifts, your insurance ought to keep pace. Insurance Agent Nick Hogan drops the dime in the latest HelloNation article, laying it bare why...

Continue Reading
BTQ's MIMIQ: A Quantum Leap for 35,000 Developers

Updated Category News Views 0

Breaking Barriers in Quantum Emulation If you think the quantum computing game is all about hardware, then you're missing half the picture. Enter BTQ Technologies, crash-landing into the scene by throwing open the doors of their MIMIQ emulator to a crowd of over 35,000 quantum developers through qBraid. This ain't just an upgrade—it's a seismic shift. More qubits, more...

Continue Reading
United Imaging Surges with 19.43% Revenue Growth in 2026

Updated Category News Views 18

United Imaging's Remarkable Revenue Surge Coming out of Shanghai, we've got some major numbers to chew on. United Imaging Healthcare (688271.SH)—this isn't your run-of-the-mill medical tech firm—is bringing some serious heat to the market with a 19.43% bump in revenue. We're talking RMB 10.58 billion raked in over just the first nine months of 2026. Those are hefty...

Continue Reading
Navigating Investment Risk: Pre-Retirement Challenges

Updated Category News Views 63

Finding the Right Investment Balance As retirement edges closer, the question often buzzing around like a relentless mosquito is: How much investment risk should we take? Investing ain't a one-size-fits-all game, and that becomes crystal clear when you're eyeing the golden years. There's a swath of choices to make, and Kevin Foreman, a financial advisor, rolls up his...

Continue Reading
Tech's Role in Shaping Tomorrow's Classroom: 2026 Insights

Updated Category News Views 113

Schools at a Crossroads: Career Skills Take Center Stage The data's out, and boy, is it telling. Project Tomorrow's 23rd Annual Speak Up Report brings a bushel of insights—some you'd expect, some that'll knock your socks off. With over 95,000 K-12 folks raising their voices, this is no small potatoes look into modern education's heartbeat. Parents Crying Out for...

Continue Reading
Savvas Launches Miller & Levine Biology Program Revamp

Updated Category News Views 66

Education Meets Innovation: Savvas Takes a Bold Step Who would have thought biology education could get a makeover that might actually stick? Savvas Learning Company thinks it's onto something with the launch of the all-new Miller & Levine Experience Biology Program. The spotlight's on innovation—it's about time someone shook up the way high schoolers learn biology. A...

Continue Reading

Top 5 Most Recently Viewed Articles

Lilly Flexes Oncology Muscle at 2026 ASCO Meet

Updated Category News Views 19

Lilly's Pipeline Gets the Spotlight With the ASCO conference kicking off in Chicago this year, Eli Lilly (NYSE: LLY) is coming in guns blazing. The company's oncology roster is vast and spread across a variety of tumor types and treatment modalities. This year's presentations are dripping with promise. You got Retevmo leading the charge in a plenary session, joined by...

Continue Reading
David Brenneman Strengthens Antitrust Practice at Latham

Updated Category News Views 212

David Brenneman Joins Latham & Watkins Latham & Watkins LLP is excited to announce a significant addition to their Antitrust & Competition Practice. Renowned antitrust lawyer David Brenneman has joined their Washington, D.C. office as a partner. Brenneman brings considerable expertise in managing the antitrust aspects of various mergers and acquisitions, enhancing the...

Continue Reading
Join the Class Action for Viatris Inc.: Important Updates

Updated Category News Views 419

Understanding the Viatris Class Action Opportunity Attention, investors! If you've purchased securities of Viatris Inc. (NASDAQ: VTRS), this is a critical time for you. The Rosen Law Firm, renowned for advocating investor rights globally, is reaching out to individuals who bought Viatris stocks during an identified time frame. Having knowledge of these events is essential...

Continue Reading
Transformative Health Education: Empowering Future Generations

Updated Category News Views 120

Understanding the Growing Health Crisis A crisis is quietly unfolding in classrooms across the nation: rising rates of preventable chronic illnesses, mental health struggles, and pervasive health illiteracy are significantly impacting the wellness of today's youth. In the face of these alarming statistics, Know Yourself Academy emerges as a beacon of hope, aiming to...

Continue Reading
Free Guide by Pacific Mind Health Eases Anxiety

Updated Category News Views 11

Wrestling with Your Inner Spotlight? Pacific Mind Health Steps In There's a good chance most of us have been there—sweatin' the small stuff like we're the star attraction in the circus of life, convinced everyone else is watching as we trip over our own shoelaces. Well, don't sweat it. Pacific Mind Health has jumped in to lend a hand with some real tools to shake off...

Continue Reading